C

Cytokinetics

Develops small-molecule therapies for muscle function

Senior Manager - Pharmacovigilance Local Contact

Biology & BiotechConfirmed live in the last 24 hours
Full-timeRemote in Germany€112k - €140k /yr

About the Job

Requirements

  • A degree in medicine, pharmacy, life sciences, or a related scientific discipline, or an equivalent combination of education, training, and relevant experience.
  • Approximately 8 or more years of progressively responsible experience in pharmacovigilance, drug safety, quality assurance, or related pharmaceutical functions.
  • Strong knowledge of German pharmacovigilance requirements, including Section 63a AMG, and European Union pharmacovigilance legislation and Good Pharmacovigilance Practices.
  • Working knowledge of applicable Austrian and Swiss pharmacovigilance requirements and experience operating within a pharmaceutical pharmacovigilance quality system.
  • Experience with regulatory authority interactions, pharmacovigilance inspections or audits, safety inquiries, product-quality investigations, and risk-management activities.
  • Ability to assess and escalate safety risks and work cross-functionally under time-sensitive conditions.
  • Fluent written and spoken German and English.
  • Must be based in Germany and have the legal right to work in Germany.

Responsibilities

  • Fulfil applicable German Stufenplanbeauftragter responsibilities under Section 63a AMG, including oversight, assessment, and escalation of medicinal product risks and German-specific pharmacovigilance requirements.
  • Act as the local pharmacovigilance contact for Austria, coordinating safety reporting, local pharmacovigilance requirements, risk-minimisation activities, and interactions with relevant authorities.
  • Where formally designated, perform Swiss Responsible Person for Pharmacovigilance responsibilities, including oversight of Swiss safety reporting and engagement with Swissmedic.
  • Ensure timely collection, documentation, reconciliation, and escalation of adverse events, safety information, and product-quality complaints with potential safety implications.
  • Coordinate safety-related actions with the European Union Qualified Person Responsible for Pharmacovigilance, Drug Safety, Quality Assurance, Regulatory Affairs, Medical Affairs, affiliates, and external partners.
  • Maintain local pharmacovigilance procedures, agreements, third-party oversight, and inspection-ready records aligned with the global pharmacovigilance system.
  • Support pharmacovigilance inspections, audits, regulatory inquiries, corrective and preventive actions, and local literature surveillance, as applicable.
  • Support pharmacovigilance training, monitor regulatory changes, and maintain appropriate escalation and business-continuity arrangements.
  • Act as the primary local pharmacovigilance representative for assigned territories and potentially support or provide back-up coverage to pharmacovigilance national contact persons in other countries.
  • Contribute to strategic and operational pharmacovigilance projects, continuous-improvement initiatives, and other activities supporting the company's global pharmacovigilance objectives.

About the Company

Cytokinetics

Develops small-molecule therapies for muscle function

Cytokinetics develops and commercializes small molecule drugs aimed at improving muscle function for cardiovascular and neuromuscular diseases. Its products are designed to either enhance or adjust muscle contraction, with a pipeline that includes compounds like omecamtiv mecarbil, reldesemtiv, CK-274, AMG 594, and CK-601, currently in various stages of clinical trials. The company advances therapies through partnerships, licensing, and potential sales of approved medicines, and relies on extensive clinical testing to demonstrate effectiveness and safety. What sets Cytokinetics apart is its focused approach on muscle function modulators (activators and inhibitors) for both heart and skeletal muscle diseases, targeting conditions such as heart failure, hypertrophic cardiomyopathy, ALS, and SMA. Its goal is to bring medicines to patients to improve muscle performance and daily function, addressing unmet medical needs in these diseases.

Company size
501-1,000
Company stage
IPO
Headquarters
South San Francisco, CA
Founded
1998

Recently Posted Jobs

Explore more opportunities at Cytokinetics

See more jobs